Emerald Health Therapeutics’ wholly-owned cannabis production facility, Verdélite, in St. Eustache, Quebec, has received from Health Canada a license amendment for the complete growing and processing area in its 88,000 square foot indoor facility. "The additional 50,000 square feet will allow Verdélite to expand production from 4 to 21 highly-controlled-environment grow rooms and to a total of 16 processing rooms," the team with the company explains. "Planting in the newly licensed area is starting immediately, with the plan focused on having the expanded facility fully planted in eight weeks."
“Verdélite is now fully built and licensed across all its growing and processing areas, and I congratulate the team for this accomplishment,” said Thierry Schmidt, President of Verdélite. “As we expand production of Emerald Health Therapeutics products sold under the Emerald sales license, this step enables us to also continue advancing our marketing strategy encompassing Verdélite brands and direct sales to provincial/territorial wholesalers and authorized Canadian private retailers.”
“This new license amendment allows Verdélite to transition into its full commercial phase and positions Verdélite as a key growth contributor to Emerald's financial results in 2020,” said Riaz Bandali, Chief Executive Officer of Emerald. “With this extended, controlled indoor growing space and Verdélite’s unique cannabis strains, we aim to bring distinct and unique consumer-driven products to the Quebec market.”
Verdélite is a vertically integrated seed-to-sale indoor operation optimized for year-round production of high-quality craft cannabis through its highly controlled environment. Its established packaging and processing line are well equipped to manage significant volume and a wide diversity of value-added products.
For more information:
Emerald Health Therapeutics